Non-drug rehabilitation of patients with chronic obstructive pulmonary disease concurrent with hypertension


Cite item

Full Text

Abstract

Aim. To evaluate the efficiency of decimeter wave therapy and halotherapy, which were additionally added to basic therapy, in patients with chronic obstructive pulmonary disease (COPD) concurrent with hypertension at the inpatient stage. Subject and methods. 36 patients aged 20 to 75 years with Stages I—II COPD concurrent with Stages I—II, first-second grade hypertension were examined and treated. The clinical examination included collection of complaints and medical history data, clinical laboratory and instrumental (electrocardiography, spirography) studies, and health-related quality of life (using the SF-36 questionnaire). The patients were randomized into two groups: a study group and a comparison group. The study group patients received decimeter wave therapy and halotherapy in addition to basic drug treatment; the comparison patients had basic drug therapy. Results. Pre- and postoperative comparative analysis of the major clinical manifestations of comorbidities revealed more pronounced positive changes with the lower rate of clinical manifestations in the study group. It was also observed to have a more marked reduction in blood pressure (BP) with its goal levels achieved. The mean pulse BP decreased by 28% in the study group (p=0.000005) and did not statistically reduced in the comparison group. In the study group patients, the integral quality-of-life indicator after a package of medical rehabilitation measures became statistically significantly higher by 35%. This indicator in the comparison group was statistically significantly unchanged. Conclusion. The directionality of the proposed rehabilitation complex towards the common pathogenetic components of the development and progression of COPD and hypertension, as well as the high efficiency of the complex justify its appropriate inclusion in the combination treatment and rehabilitation of this category of patients.

References

  1. Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukelet TA. Combination long-acting β-Agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease. JAMA. 2014;312(11):1114-1121. doi: 10.1001/jama.2014.11432
  2. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990—2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-171. doi: 10.1016/s0140-6736(14)61682-2
  3. Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Star Rep. 2012;61:1-51.
  4. Chuchalin AG, Khaltaev N, Antonov NS, Galkin DV, Manakov LG, Antonini P, Murphy M, Solodovnikov AG, Bousquet J, Pereira MHS, Demko IV. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014;9(1):963-974. doi: 10.2147/copd.s67283
  5. Колосов В.П., Трофимова А.Ю., Нарышкина С.В. Качество жизни больных хронической обструктивной болезнью легких. Благовещенск; 2011.
  6. Murray CJL, Lopez AD. Measuring the global burden of disease. N Eng J Med. 2013;369:448-457. doi: 10.1056/NEJMra1201534
  7. Акрамова Э.Г., Хамитова Р.Я. Сопутствующая кардиальная патология у больных хронической обструктивной болезнью легких: диагностика и экономика. Терапевтический архив. 2014;3:24-27.
  8. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIn N. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Critical Care Med. 2006;173(12):1390-1413. doi: 10.1164/rccm.200508-1211st
  9. Bolton CE, Singh SJ, Walker PP. Commentary: the British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;68(9):887-888. doi: 10.1136/thoraxjnl-2013-203809
  10. Овчаренко С.И., Морозова Т.Е., Нерсесян З.Н. Хроническая обструктивная болезнь легких в сочетании с артериальной гипертонией: оценка лечебного эффекта индапамида пролонгированного действия Терапевтический архив. 2015;8:44-50.
  11. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002;166:333-339. doi: 10.1164/rccm.2110093
  12. Диагностика и лечение артериальной гипертензии (Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов). Системные гипертензии. 2010;3:5-26.
  13. Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине. М.: ЗАО «ОЛМА Медиа Групп»; 2007.
  14. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress and risk of cardiovascular events in patients with coronary disease. Circulation. 2001;104(22):2673-2678. doi: 10.1161/hc4601.099485
  15. Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don’t know (but should). Proc Am Thorac Soc. 2007;4(7):522-525. doi: 10.1513/pats.200701-004fm
  16. Даниленко С.А., Ландышев Ю.С. Микрогемоциркуляторные нарушения в слизистой оболочке бронхов при хронической обструктивной болезни легких. Регионарное кровообращение и микроциркуляция. 2010;1:38-41.
  17. Адашева Т.В., Задионченко В.С., Мациевич М.В., Ли В.В., Шилова А.В., Федорова И.В. Артериальная гипертония и ХОБЛ — рациональный выбор терапии. Русский медицинский журнал. 2006;10(262):795-800.
  18. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87(5):1468-1474. doi: 10.1161/01.cir.87.5.1468
  19. Ахминеева А.Х. Биохимические маркеры дисфункции эндотелия при хронической обструктивной болезни легких в сочетании с гипертонической болезнью, ишемической болезнью сердца. Терапевтический архив. 2014;86(3):20-23.
  20. Боголюбов В.М., Пономаренко Г.Н. Общая физиотерапия. Учебник для студентов медицинских ВУЗов. М.: Медицина; 2003.
  21. Клячкин Л.М., Щегольков А.М. Медицинская реабилитация больных с заболеваниями внутренних органов: Руководство для врачей. М.: Медицина; 2000.
  22. Сорокина Е.И., Львова Н.В. СВЧ-терапия больных гипертонической болезнью. Вопросы курортологии, физиотерапии и ЛФК. 1996;5:3-5.
  23. Лян Н.А., Хан М.А., Иванова Д.А., Чукина И.М. Физические факторы в реабилитации детей с бронхиальной астмой. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2012;6:47-53.
  24. Червинская А.В. Галотерапия в условиях управляемого микроклимата соляных пещер для восстановительной медицины. Нелекарственная медицина. 2007;3(8):6-15.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies